Kiguba Ronald, Karamagi Charles, Bird Sheila M
Department of Pharmacology and Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda.
Clinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda.
BMJ Open. 2017 Jan 20;7(1):e010568. doi: 10.1136/bmjopen-2015-010568.
To determine the incidence and risk factors of hospital-acquired suspected adverse drug reactions (ADRs) among Ugandan inpatients. We also constructed risk scores to predict and qualitatively assess for peculiarities between low-risk and high-risk ADR patients.
Prospective cohort of consented adults admitted on medical and gynaecological wards of the 1790-bed Mulago National Referral Hospital. Hospital-acquired suspected ADRs were dichotomised as possible (possible/probable/definite) or not and probable (probable/definite) or not, using the Naranjo scale. Risk scores were generated from coefficients of ADR risk-factor logistic regression models.
The incidence of possible hospital-acquired suspected ADRs was 25% (194/762, 95% CI: 22% to 29%): 44% (85/194) experienced serious possible ADRs. The risk of probable ADRs was 11% (87/762, 95% CI 9% to 14%): 46% (40/87) had serious probable ADRs. Antibacterials-only (51/194), uterotonics-only (21/194), cardiovascular drugs-only (16/194), antimalarials-only (12/194) and analgesics-only (10/194) were the most frequently implicated. Treatment with six or more conventional medicines during hospitalisation (OR=2.31, 95% CI 1.29 to 4.15) and self-reported herbal medicine use during the 4 weeks preadmission (OR=1.96, 95% CI 1.22 to 3.13) were the risk factors for probable hospital-acquired ADRs. Risk factors for possible hospital-acquired ADRs were: treatment with six or more conventional medicines (OR=2.72, 95% CI 1.79 to 4.13), herbal medicine use during the 4 weeks preadmission (OR=1.68, 95% CI 1.16 to 2.43), prior 3 months hospitalisation (OR=1.57, 95% CI 1.09 to 2.26) and being on gynaecological ward (OR=2.16, 95% CI 1.36 to 3.44). More drug classes were implicated among high-risk ADR-patients, with cardiovascular drugs being the most frequently linked to possible ADRs.
The risk of hospital-acquired suspected ADRs was higher with preadmission herbal medicine use and treatment with six or more conventional medicines during hospitalisation. Our risk scores should be validated in large-scale studies and tested in routine clinical care.
确定乌干达住院患者中医院获得性疑似药物不良反应(ADR)的发生率及危险因素。我们还构建了风险评分,以预测并定性评估低风险和高风险ADR患者之间的差异。
对穆拉戈国家转诊医院1790张床位的内科和妇科病房中同意参与的成年患者进行前瞻性队列研究。使用纳兰霍量表将医院获得性疑似ADR分为可能(可能/很可能/肯定)或不可能,以及很可能(很可能/肯定)或不可能。从ADR危险因素逻辑回归模型的系数生成风险评分。
医院获得性疑似可能ADR的发生率为25%(194/762,95%置信区间:22%至29%):44%(85/194)经历了严重的可能ADR。很可能ADR的风险为11%(87/762,95%置信区间9%至14%):46%(40/87)发生了严重的很可能ADR。仅使用抗菌药物(51/194)、仅使用宫缩剂(21/194)、仅使用心血管药物(16/194)、仅使用抗疟药(12/194)和仅使用镇痛药(10/194)是最常涉及的药物。住院期间使用六种或更多常规药物(比值比=2.31,95%置信区间1.29至4.15)以及入院前4周内自我报告使用草药(比值比=1.96,95%置信区间1.22至3.13)是医院获得性很可能ADR的危险因素。医院获得性可能ADR的危险因素为:使用六种或更多常规药物(比值比=2.72,95%置信区间1.79至4.13)、入院前4周内使用草药(比值比=1.68,95%置信区间1.16至2.43)、既往3个月内住院(比值比=1.57,95%置信区间1.09至2.26)以及在妇科病房(比值比=2.16,95%置信区间1.36至3.44)。高风险ADR患者涉及的药物类别更多,心血管药物与可能的ADR关联最为频繁。
入院前使用草药以及住院期间使用六种或更多常规药物会增加医院获得性疑似ADR的风险。我们的风险评分应在大规模研究中进行验证,并在常规临床护理中进行测试。